SESSION 3: COVID-19, Programmatic, Clinical and Biological Interactions

14:45 –  Innovative TB Programming Within the Context of COVID-19 (VIRTUAL)

Lucica Ditiu, MD, Stop TB Partnership, Switzeland

15:10 – Biologic Interactions Between COVID-19 and HIV (VIRTUAL)

Penny Moore, PhD, National Institute for Communicable Diseases, South Africa

15:35 – Audience Q&A 



Location: Date: 05/10/2022 Time: 2:45 pm - 3:45 pm Lucica Ditiu Penny Moore